Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jordan Nester

Orthopaedic Surgery Gaylord, MI Medical Doctor

NPI 1689106270 CMS profile 3663912

2147 Professional Dr, Gaylord, MI 49735

Open in the dashboard

General payments

$35,500

128 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jordan Nester of Gaylord, MI is reported in the CMS Open Payments database as having received $35,500 across 128 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,124 40
2024 General $448 10
2023 General $2,193 33
2022 General $22,160 13
2021 General $4,257 10
2020 General $213 6
2019 General $1,105 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jordan Nester
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Jordan Nester were reported at $5,124. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Jordan Nester Orthopaedic Surgery median Middle half National median
2019 $1,105 $644 $140–$2,844 $163
2020 $213 $312 $75–$1,860 $114
2021 $4,257 $520 $117–$2,495 $132
2022 $22,160 $598 $128–$2,731 $149
2023 $2,193 $461 $128–$2,264 $160
2024 $448 $497 $134–$2,475 $164
2025 $5,124 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $23,504 48 payments
  2. Novus Surgical Solutions LLC $3,670 4 payments
  3. Stryker Corporation $2,438 35 payments
  4. Zak Ortho $2,218 11 payments
  5. Alon Medical Technology $1,300 3 payments
  6. Smith+Nephew, Inc. $414 4 payments
  7. Lightbody Medical Technologies Inc $318 4 payments
  8. Acumed LLC $293 2 payments
  9. DePuy Synthes Sales Inc. $267 2 payments
  10. Medwest Associates $184 2 payments
  11. Other $893 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $20,000 1 payment
  2. Food and Beverage $5,924 103 payments
  3. Education $4,800 3 payments
  4. Travel and Lodging $4,776 21 payments
Products named General payments · program years 2019–2025
  1. MAKO $1,167 19 payments
  2. REUNION $642 4 payments
  3. ADAPT $470 1 payment
  4. T2 $470 1 payment
  5. GAMMA Trauma & Extremeties $470 1 payment
  6. TRITANIUM $422 10 payments
  7. MOBILE BEARING HIP SYSTEM $341 5 payments
  8. Bone Anchors with Arthroscopic Delivery System $257 2 payments
  9. TRIDENT $249 5 payments
  10. GAMMA Trauma & Extremeties $207 3 payments
  11. Other $4,322 64 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$31,345

Of which drugs: $1,305

Medicare patients

96

Average age 72

Services billed

649

56 women, 40 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Depression 26%
Chronic kidney disease 25%
Ischemic heart disease 20%
Diabetes 19%
Osteoporosis 18%
Atrial fibrillation 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 34 332 $250

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ERLEADA
  • Janssen Biotech, Inc. $32
$32 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

128 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record